Creating a High-ROI Admissions Marketing Strategy

Cost per admission is not a marketing metric. It is the output of four variables, and three of them sit outside the marketing department. Operators who treat it as a vendor scorecard miss where the real leverage lives.

• The first variable is qualified call volume, defined by clinical and payer fit, not raw inbound count.
• The second is the qualified-to-admission conversion rate, which is set by the admissions team’s response time, intake script, and verification process more than by ad creative.
• The third is average revenue per admission, which depends on payer mix and authorized length of stay.
• The fourth is fully-loaded marketing spend, which includes media, agency fees, content production, call tracking, and the labor hours admissions staff spend handling unqualified inquiries.

Changing any one variable moves the equation. A center that improves its qualified conversion rate from 18% to 24% lowers cost per admission without spending an additional dollar on media. A center that adds a high-acuity payer to its contracted list raises revenue per admission and changes which channels are worth running.

The structure operators should populate looks like this: qualified calls multiplied by the qualified-to-admission conversion rate produces admissions. Admissions multiplied by average revenue per admission, adjusted for actual authorized length of stay, produces gross revenue. Subtract fully-loaded marketing spend from contribution margin, not from top-line revenue, and the result is the true return on the channel.

HFMA’s framework for telebehavioral health ROI applies the same logic finance leaders use elsewhere: weigh implementation and operating costs against measurable downstream value, and assign assumptions where data is incomplete ¹⁸. Treatment centers can adapt this structure without inventing benchmarks. The variables are populated from the center’s own admissions data, payer contracts, and accounting system.

Three disciplines make the math honest:

• Qualified calls must be defined by a written rubric (insurance verified, clinical fit confirmed, geography in service area), not by call duration.
• Revenue per admission must be calculated on collected revenue, not billed charges.
• Fully-loaded spend must include the admissions team’s time on unqualified inquiries, because cheap leads that consume staff hours are not cheap.

Operators running this structure quarterly catch channel decay before it shows up on the census report. A channel that produced a 22% conversion rate last quarter and 14% this quarter is signaling either lead quality drift or an intake process problem, and the math points to which.

Sessions, impressions, click-through rates, and total form fills do not pay payroll. They appear on dashboards because they are easy to count, not because they predict revenue. Operators reviewing monthly marketing reports should strike four categories on sight:

• Total leads without a qualification breakdown. A 400-lead month and a 120-lead month can produce identical admissions if the 120 are pre-qualified by clinical fit and payer.
• Cost per lead, because it ignores conversion.
• Branded search traffic counted as a marketing win, since branded queries usually reflect referral, alumni, and reputation activity, not paid acquisition.
• Social media engagement metrics when no admission has ever been traced to the channel.

The replacement set is short: qualified calls, qualified-to-admission rate, payer-aligned admission rate, cost per admission, and length-of-stay-adjusted contribution margin per admission. Five numbers, reviewed weekly, tell the operator whether the pipeline is working.

Channels are not interchangeable. A residential program with two open detox beds and a six-week wait for PHP needs demand that matches detox acuity this week, not paid traffic for outpatient keywords that will produce inquiries the clinical team cannot place. Operators who buy demand without checking the bed board produce two outcomes: unqualified call volume that burns admissions staff time, and qualified callers who are told to wait and choose another provider.

The mapping is straightforward. Detox and inpatient acuity respond to high-intent search and crisis-oriented organic content, where inquiry urgency matches bed turnover. PHP and IOP fill from referral relationships, alumni networks, and longer-form content that supports a slower decision cycle. Telehealth-eligible outpatient demand draws from broader geographic search and content that addresses access barriers like transportation and stigma, which HHS identifies as primary drivers of telebehavioral health adoption ¹⁷.

Operators should set channel budgets against a rolling 30-day capacity forecast by level of care, not an annual media plan. When detox capacity tightens, paid search shifts down and referral cultivation shifts up.

Qualified call volume hides a second filter that decides whether the math works: the payer-aligned admission rate. A channel producing 40 qualified calls per month where only 12% carry a contracted commercial payer is a different business than a channel producing 25 calls where 60% carry contracted payers. Same conversion math, very different contribution margin.

Each channel carries a payer signature. Branded organic and alumni referral typically over-index on commercial PPO inquiries. Generic high-volume paid search often pulls a higher share of Medicaid, out-of-network, and self-pay callers, depending on geography and ad copy. Community referral from hospitals and EAPs varies by the referring entity’s own payer mix. Operators should tag every qualified call by payer at intake and roll up the payer-aligned admission rate by source quarterly.

The filter is operational, not theoretical. A channel that produces good gross call volume but a 9% payer-aligned admission rate gets cut or repositioned toward a level of care where its payer mix actually clears.

The size of the behavioral health telehealth shift is easy to underestimate from a 2024 vantage point. Medicare telehealth visits rose 63-fold between 2019 and 2020, climbing from roughly 840,000 visits in 2019 to 52.7 million in 2020, and behavioral health providers posted the highest telehealth utilization of any specialty group in that period ¹. The scope matters: this figure tracks Medicare beneficiaries during the pandemic surge, not the entire treatment market, and not every payer behaves the way Medicare did.

Even with that scope in mind, the number changed what payers expect, what referral sources assume is available, and what prospective patients search for. Inquiries that once asked only about location now ask whether assessments, therapy, and medication management can start virtually before a patient travels for higher levels of care. Treatment centers running paid search and organic content without a clear answer to that question lose qualified callers to competitors who do.

The peak figures are not the operating reality. The more useful number for admissions planning is where telehealth claims settled after the initial surge cleared.

A peer-reviewed analysis of commercial and Medicare supplemental claims covering roughly 26 million lives tracked the transition from January 2020 through November 2021. Telehealth claims for mental health diagnoses surged above 51% of all mental health claims in April 2020, then stabilized at roughly 30% of mental health diagnosis claims through the study window. SUD telehealth claims rose from under 1% in February 2020 to nearly 14% in April 2020, then plateaued near 10% of all SUD claims ¹³. CMS’s own trend analysis confirms the directional pattern: total telehealth use declined between 2020 Q2 and 2023 Q1, while behavioral health remained the most frequently used telehealth service category ⁵.

A 30% mental health share and a 10% SUD share are not residual numbers. They are large enough to shape how a center forecasts inquiry volume, how it staffs virtual intake, and how it prices the channel against in-person admissions. Provider adoption has held steady alongside the claims data, with post-pandemic surveys reporting that telehealth use in behavioral health care remained high even as in-person care returned ²⁰.

Marketing claims about telehealth carry compliance risk if the clinical record does not back them up. The evidence base does.

AHRQ’s review of systematic reviews concludes telehealth improves outcomes, utilization, and cost of care for depression, mental health conditions, and several chronic diseases ⁶. A community-based study comparing telehealth and in-person mental health care found no significant differences in depressive symptom reduction between modalities ¹⁰. A separate comparison across behavioral health grant recipients reported workable symptom outcomes in telebehavioral settings versus in-person care ¹². An evidence brief covering PTSD, depression, anxiety, and SUD reaches similar conclusions across populations ⁹.

The channel fails when intake operations treat virtual inquiries as a lighter version of in-person ones. Three failure points show up repeatedly:

• Acuity mismatch. Detox and medically managed withdrawal cannot start on a video call, and a virtual intake that promises immediate help to a caller who needs inpatient care produces a disappointed handoff.
• Geography and licensure. Providers must be licensed where the patient is located, and admissions teams that schedule virtual assessments without verifying patient state lose those visits at the clinician’s calendar.
• Technology access. HHS notes telehealth reduces transportation and stigma barriers but introduces device, broadband, and privacy barriers that disproportionately affect rural and lower-income patients ¹⁷.

Centers that scale telehealth admissions build a triage script that routes by acuity, verifies state of residence before booking, and offers a phone-only fallback when video is not workable.

HIPAA’s Privacy Rule defines marketing broadly, and that definition decides which admissions tactics need written patient authorization before they can run. HHS guidance is direct: with limited exceptions, a covered entity must obtain an individual’s written authorization before using or disclosing protected health information for marketing ¹⁴. The exceptions are narrow. Face-to-face communications with the patient and promotional gifts of nominal value do not require authorization ^{14, 15}.

What is not marketing under the rule matters as much as what is. Communications that describe the covered entity’s own health-related products and services, treatment communications, and care coordination messages generally fall outside the marketing definition, which gives admissions teams room to maintain alumni outreach, appointment reminders, and clinical follow-up without separate authorizations ¹⁹. The line gets harder at digital edges. Any sale or exchange of PHI for remuneration is tightly controlled, and disclosures of PHI to other entities in exchange for remuneration tied to their marketing fall under the same authorization requirements ¹⁵.

For admissions operations, the practical test is whether a communication encourages purchase or use of a product or service, whether PHI is being used to target it, and whether a third party is being paid in connection with it. Communications that meet those conditions need a HIPAA-compliant authorization on file before the campaign runs, not after a complaint arrives.

The Eliminate Kickbacks in Recovery Act sits on top of HIPAA and changes which referral and lead-acquisition arrangements are even available to SUD treatment centers. EKRA defines patient brokering as paying or receiving a referral fee to steer a patient to a treatment provider, and it makes that conduct a federal felony punishable by up to 10 years in prison ¹⁶.

States have layered their own statutes on the federal baseline. North Carolina’s 2024 law makes patient brokering a Class G felony and broadens the prohibited consideration to anything of value paid or received for a referral, not just cash ¹⁶. Other states are following a similar pattern, expanding what qualifies as remuneration and extending criminal liability to intermediaries and marketers, not only the treatment provider on the receiving end.

Three categories of tactics common in other healthcare verticals do not survive the HIPAA and EKRA overlay for SUD treatment admissions.

• Pay-per-call and pay-per-admission lead vendors. Any arrangement where compensation moves on a per-patient basis, regardless of how it is labeled, falls inside EKRA’s definition of remuneration for a referral ¹⁶. Flat-fee media buys and salaried admissions staff do not. Variable compensation tied to admission volume does.
• Referral fees to alumni, sober living operators, interventionists, or affiliate websites. Anything of value, including discounted services, free rent, or in-kind benefits, can satisfy state patient brokering statutes that have expanded beyond cash ¹⁶.
• PHI-fueled retargeting. Using patient identifiers, intake form data, or third-party tracking pixels to build custom audiences for paid media is a use of PHI for marketing and requires written authorization under the Privacy Rule ^{14, 15}. The compliant alternative is non-PHI audience targeting built from aggregated, de-identified data and contextual signals, not patient-level information.

The intake phone is where most admissions marketing budgets quietly fail. A center can buy clean, high-intent calls and still post a flat census if the qualified-to-admission rate sits in the teens. The bottleneck is rarely lead quality. It is response time, verification speed, clinical triage, and how the first ninety seconds of the call are scripted.

Three operational metrics decide whether a qualified call becomes an admission:

1. Speed to answer, measured in seconds and tracked by hour of day. Inbound calls that hit voicemail outside business hours convert at a fraction of calls answered within thirty seconds.
2. Insurance verification turnaround, measured from call end to verified benefits. Centers that verify within an hour hold the caller; centers that take a day lose them to a competitor.
3. Clinical triage accuracy, measured by how often the admissions team correctly routes acuity, level of care, and telehealth eligibility on the first call.

Operators reviewing channel performance without these three numbers are debugging the wrong system.

Standard marketing attribution stacks were not built for covered entities. Third-party pixels, session replay tools, and conversion tags that pass identifiers or intake form fields to advertising platforms create a PHI disclosure problem that HHS treats as marketing requiring authorization ^{14, 15}.

A defensible attribution setup runs on three components:

• Server-side call tracking that maps phone numbers to source channels without sending caller data to ad platforms.
• First-party analytics configured to strip identifiers before any data leaves the center’s environment.
• A manual reconciliation step where the admissions team tags each admitted patient by referral source at intake, then rolls up source-to-admission data inside the EHR rather than inside the ad platform.

The output is less granular than a typical ecommerce attribution model. It is also legal. Operators who insist on parity with ecommerce attribution either accept regulatory risk or hand their PHI to vendors who do.

Monthly reporting is too slow for an admissions pipeline. Channel decay, intake breakdowns, and payer mix shifts all show up inside a four-week window, and a monthly review catches them after the census has already moved.

A weekly cadence runs on five numbers per channel:

• Qualified calls
• Qualified-to-admission rate
• Payer-aligned admission rate
• Cost per admission
• Average authorized length of stay for that source

Anything that trends down for two consecutive weeks gets a diagnostic conversation, not another month of spend. Anything that holds or improves keeps its budget. Channels that produce qualified calls at acceptable cost but a payer-aligned admission rate below the center’s threshold get repositioned toward a level of care where the payer mix clears, or cut.

The discipline is the same one finance leaders apply to any operating expense: spend follows performance, and performance is measured against the variables that actually move contribution margin ¹⁸.